Hsu Chi-Jen, Ma Yongguang, Xiao Peilun, Hsu Chia-Chien, Wang Dawei, Fok Mei Na, Peng Rong, Xu Xianghe, Lu Huading
Department of Orthopedics, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Front Pediatr. 2023 May 23;11:1103565. doi: 10.3389/fped.2023.1103565. eCollection 2023.
Ewing sarcoma (ES) is a common primary bone tumor in children. Our study aimed to compare overall survival (OS) between pediatric and adult bone ES patients, identify independent prognostic factors and develop a nomogram for predicting OS in adult patients with ES of bone.
We retrospectively analyzed data for the 2004-2015 period from the Surveillance, Epidemiology, and End Results (SEER) database. To guarantee well-balanced characteristics between the comparison groups, propensity score matching (PSM) was used. Kaplan-Meier (KM) curves were used to compare OS between pediatric and adult patients with ES of bone. Univariate and multivariate Cox regression analyses were used to screen independent prognostic factors for ES of bone, and a prognostic nomogram was constructed by using the factors identified. The prediction accuracy and clinical benefit were evaluated using receiver operating characteristic (ROC) curves, areas under the curves (AUCs), calibration curves, and decision curve analysis (DCA).
Our results showed that adult ES patients had lower OS than younger ES patients. Age, surgery, chemotherapy, and TNM stage were independent risk factors for bone ES in adults and were used to develop a nomogram. AUCs for 3-, 5-, and 10-year OS were 76.4 (67.5, 85.3), 77.3 (68.6, 85.9) and 76.6 (68.6, 84.5), respectively. Calibration curves and DCA results indicated excellent performance for our nomogram.
We found that ES pediatric patients have better OS than adult ES patients, and we constructed a practical nomogram to predict the 3-, 5- and 10-year OS of adult patients with ES of bone based on independent prognostic factors (age, surgery, chemotherapy, T stage, N stage and M stage).
尤因肉瘤(ES)是儿童常见的原发性骨肿瘤。我们的研究旨在比较儿童和成人骨ES患者的总生存期(OS),确定独立的预后因素,并开发一种用于预测成人骨ES患者OS的列线图。
我们回顾性分析了监测、流行病学和最终结果(SEER)数据库2004 - 2015年期间的数据。为确保比较组之间特征均衡,采用了倾向评分匹配(PSM)。使用Kaplan - Meier(KM)曲线比较儿童和成人骨ES患者的OS。采用单因素和多因素Cox回归分析筛选骨ES的独立预后因素,并使用确定的因素构建预后列线图。使用受试者工作特征(ROC)曲线、曲线下面积(AUC)、校准曲线和决策曲线分析(DCA)评估预测准确性和临床效益。
我们的结果显示,成人ES患者的OS低于年轻ES患者。年龄、手术、化疗和TNM分期是成人骨ES的独立危险因素,并用于开发列线图。3年、5年和10年OS的AUC分别为76.4(67.5,85.3)、77.3(68.6,85.9)和76.6(68.6,84.5)。校准曲线和DCA结果表明我们的列线图具有良好的性能。
我们发现儿童ES患者的OS优于成人ES患者,并且我们基于独立预后因素(年龄、手术、化疗、T分期、N分期和M分期)构建了一个实用的列线图,用于预测成人骨ES患者的3年、5年和10年OS。